Pharmacology of Opioid Analgesics Flashcards
Analgesia definition
block pain neurotransmission; antinociception
Anesthesia definition
block sensory neurotransmission; pain, motor and autonomic pathways
Nociception definition
pain sensation
qd
once daily
bid
twice a day
Q12
every 12 hrs
tid
three times a day
qid
four times a day
What happens when tissue is damaged
release of cytokines, chemical mediators
increase vascularization, sensitize somatosensory nervous system, promote recovery
Types of pain
thermal, mechanical, and chemical
Co-morbidities with chronic pain
anxiety, depression, insomnia/disrupted sleep, activation of glia, hyperalgesia, allodynia
How are pain signals transmitted
pain signals are transmitted to the CNS where different aspects of the pain signal are processed by specific brain regions
Assigns aversive or pleasurable qualities to pain
nucleus accumbens
Involved with fear processing associated with pain expectation
amygdala
important for determining what action should be taken to deal with pain (fight or flight)
frontal cortex
Key brain regions expression opioid receptors
- periagueductal gray (PAG)
- rostral ventral medulla (RVM)
- dorsal root ganglion (drg)/dorsal horn
Two types of alkaloids that opium contains
- Phenanthrenes
2. Benzylisoquinolines
Mu opioid receptor structures can be divided into
phenanthrene and non-phenanthrene alkaloids
Phenanthrene opioids primarily show differences where
at the 3 and 6 position
How is antagonist of phenanthrene opioids conferred
conferred by bulky side groups indicated in the red circle
Why is it worthwhile to switch between phenanthrene and non-phenanthrene opioids in patients that are not responsive/show strong side effects to one type
it is suggested that some patients respond better to phenanthrene than non-phenanthrene opioids and vice versa
Phenanthrenes
morphine, hydrocodone, buprenorphine, naloxone
Non-phenanthrenes
tramadol, meperidine, fentanyl, and methadone
Metabolism of phenanthrene opioids occurs primarily by
glucorinidation at the 3 and 6 position
Activity of morphine-6-glucoronide
metabolite that is still pharmacologically active
Where is morphine/phenanthrenes metabolized
large hepatic (CYP2D6) and can be impaired by patients with liver disease or genetic difference in the make up of their liver enzymes
Where is morphine/phenanthrenes excreted?
excreted through the kidneys by glomerular filtration
Describe opioid receptors
G protein-coupled receptors
family A- peptide receptors
Gi/o - coupled (inhibition of cAMP production)
Three types of opioid receptors
Mu, Kappa, Delta, Nociceptin orphanin FQ receptor
Are there currently kappa or delta opioid-selective FDA approved drugs
No
Therapeutic targets for the mu opioid receptor
analgesia (not acute sharp localized pain, not neuropathic pain, cancer pain, peripheral, PCA)
sedation
antitussive (supress cough reflex)
Natural ligand for the mu opioid receptor?
beta-endorphine (endogenous morphine)
pro-opiomelanocortin (POMC)
“runners high”
Side effects from the mu opioid receptor
respiratory depression, constipation, pruritis, tolerance/dependent, urinary retention, nausea/vomiting, muscle rigidity, miosis
Kappa opioid receptor are involved in what type of feedback loop
negative feedback loop, inhibiting the release of dopamine
Describe the negative feedback loop with the kappa opioid receptor
initial release of dopamine causes transcription of dynorphin, the endogenous kappa opioid agonist; release of dynorphin will activate presynaptic Kappa receptors on dopaminergic terminals, inhibiting further release of dopamine
Endogenous kappa opioid agonist
dynorphin
Kappa opioid receptor has potential for use of treatment of
addiction
Salivinorin A
Kappa opioid receptor agonist, not an alkaloid
Delta opioid receptors are being considered as target for
anxiety, depressive and alcohol use disorders, preventing ischemic damage
Natural ligands for the delta opioid receptor
enkephalins
Endogenous peptides released during hibernation act on which receptors
delta receptors
When are delta opioid receptors upregulated
during chronic stimulation, such as during chronic inflammation and nerve damage, thus making it an interested target for treatment of chronic pain
Effect of Mu opioid receptor activation
analgesia, euphoria and mood effects, respiratory depression, miosis, neuroendocrine regulation, decreased GI motility, autonomic regulation, tolerance and withdrawal
Endogenous Mu opioid receptor peptide affinity
Endorphins
Effect of Kappa opioid receptor activation
analgesia, diuresis, sedation, dysphoria and psychotomimetic, less miosis, less respiratory depression, little dependence
Effect of Delta opioid receptor activation
analgesia, mood, hypoxia, chronic pain, alcohol addiction
Effect of Orphanin opioid-receptor-like sybtype 1 (ORL1), Nociceptin receptor activation
controversy actions, opposes classic mu effects, mediate pain
Endogenous ORL1, Nociceptin peptide affinity
Nociceptin/Orphanin FQ